Tandem Diabetes Care, Inc. is recalling approximately 171,750 t:slim X2 insulin pumps across several models, including G5, Basal-IQ, and Control-IQ versions. These pumps may have been manufactured with defective internal speakers that can cause a 'Malfunction 16' error, making the pump inoperable and preventing audible alerts. If the pump stops delivering insulin without warning, the user could experience dangerously high blood sugar (hyperglycemia) which can lead to serious injury or hospitalization. These battery-operated pumps are used for the delivery of insulin in people with diabetes.
The internal speaker may fail, triggering a malfunction that completely stops insulin delivery and silences all alarms. This poses a critical risk of severe hyperglycemia or diabetic ketoacidosis because the user will not receive necessary insulin or the audible alerts intended to warn them of the pump's failure.
Manufacturer support and medical consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.